RE: AGM RNS4 Jun 2020 16:22
cancers in an area where CAR-T based treatment has had some success but where current efficacy and safety is far from perfect.
The Directors believe that a number of developments, in particular those mentioned above, have shown excellent results to date and look forward to taking these forward effectively in the coming months.